Market Insights Consumer OTC Pharmaceuticals

Wound Care - Indonesia

Indonesia

Revenue in the Wound Care market amounts to €26.19 in 2024. The market is expected to grow annually by 0.59% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€975 in 2024).
In relation to total population figures, per person revenues of €0.09 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Wound Care market in Indonesia has been experiencing significant growth in recent years, driven by several key factors.

Customer preferences: In Indonesia, customers have shown a growing preference for advanced wound care products and technologies. This is primarily due to an increasing awareness of the importance of wound care and the availability of innovative solutions. Customers are seeking products that can provide faster healing, minimize pain, and reduce the risk of infection. They are also looking for products that are easy to use and can be self-administered at home.

Trends in the market: One of the major trends in the Wound Care market in Indonesia is the adoption of advanced wound dressings. Traditional wound dressings, such as gauze and adhesive bandages, are being replaced by more advanced options like hydrocolloids, foams, and films. These advanced dressings offer better moisture management, enhanced wound healing properties, and improved patient comfort. Another trend in the market is the increasing demand for negative pressure wound therapy (NPWT) devices. NPWT is a non-invasive technique that uses controlled suction to promote wound healing. It has gained popularity in Indonesia due to its effectiveness in managing complex wounds, such as diabetic foot ulcers and pressure ulcers. The demand for NPWT devices is expected to continue to rise as healthcare professionals become more aware of its benefits.

Local special circumstances: Indonesia is a country with a large population and a significant burden of chronic diseases, such as diabetes and cardiovascular diseases. These conditions often lead to chronic wounds that require specialized care. The prevalence of chronic wounds, coupled with the increasing healthcare expenditure in the country, has created a favorable environment for the growth of the Wound Care market in Indonesia.

Underlying macroeconomic factors: The growing middle class in Indonesia has contributed to the expansion of the healthcare sector, including wound care. As people's disposable income increases, they are more willing to spend on healthcare products and services, including advanced wound care solutions. Additionally, the government's focus on improving healthcare infrastructure and access to healthcare services has also played a role in the growth of the Wound Care market in Indonesia. In conclusion, the Wound Care market in Indonesia is experiencing growth due to customer preferences for advanced wound care products, the adoption of advanced dressings and NPWT devices, the prevalence of chronic diseases, and the country's growing middle class. These factors, along with the government's efforts to improve healthcare infrastructure, are driving the development of the market in Indonesia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.